We are live on ! Find out more
HIM

Hillhouse Investment Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 7.29%
This Fund
S&P 500
This Quarter Est. Return
-29.33%
1 Year Est. Return
-7.29%
3 Year Est. Return
+122.05%
5 Year Est. Return
+101.44%
10 Year Est. Return
AUM
$1.34B
AUM Growth
-$2.41B
Cap. Flow
-$1.74B
Cap. Flow %
-130.67%
Top 10 Hldgs %
92.55%
Holding
52
New
2
Increased
8
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$675M
2
UXIN
Uxin Ltd
UXIN
+$117M
3
META icon
Meta Platforms (Facebook)
META
+$25.2M
4
MRNA icon
Moderna
MRNA
+$16.1M
5
AAPL icon
Apple
AAPL
+$8.66M

Sector Composition

Rank Sector Weight
1 Communication Services 42.21%
2 Financials 23.87%
3 Consumer Discretionary 16.35%
4 Healthcare 15.52%
5 Technology 1.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
26
DELISTED
Blueprint Medicines
BPMC
-1,430,949
Closed -$112M
KYNB
27
Kyntra Bio
KYNB
$28.2M
-107,448
Closed -$163M
IDXX icon
28
Idexx Laboratories
IDXX
$46.9B
-33,380
Closed -$8.33M
KNSA icon
29
Kiniksa Pharmaceuticals
KNSA
$5.97B
-1,388,888
Closed -$35.4M
MCO icon
30
Moody's
MCO
$82.8B
-89,949
Closed -$15M
MDLZ icon
31
Mondelez International
MDLZ
$78.5B
-3,529,264
Closed -$152M
MLCO icon
32
Melco Resorts & Entertainment
MLCO
$2.12B
-913,329
Closed -$19.3M
NKE icon
33
Nike
NKE
$62.5B
-143,741
Closed -$12.2M
SNAP icon
34
Snap
SNAP
$9.05B
-10,989,529
Closed -$93.2M
SOHU
35
Sohu.com
SOHU
$376M
-802,034
Closed -$15.9M
SPGI icon
36
S&P Global
SPGI
$121B
-24,387
Closed -$4.76M
TAL icon
37
TAL Education Group
TAL
$6.93B
-2,024,450
Closed -$52M
VRSN icon
38
VeriSign
VRSN
$26.5B
-75,711
Closed -$12.1M
JOYY
39
JOYY Inc
JOYY
$3.77B
-193,490
Closed -$14.5M
GTHX
40
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-949,431
Closed -$49.6M
KA
41
DELISTED
Kineta, Inc. Common Stock
KA
-6,185
Closed -$2.09M
FTCH
42
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-500,000
Closed -$13.6M
SFUN
43
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
-30,000
Closed -$3.88M
NEW
44
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
-90,349
Closed -$7.9M
XLRN
45
DELISTED
Acceleron Pharma
XLRN
-813,600
Closed -$46.6M
EIDX
46
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
-225,000
Closed -$2.25M
LN
47
DELISTED
LINE Corporation
LN
-1,207,763
Closed -$50.9M
MYOK
48
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-858,340
Closed -$56M
WUBA
49
DELISTED
58.com Inc
WUBA
-2,638,675
Closed -$194M
LOXO
50
DELISTED
Loxo Oncology, Inc
LOXO
-131,300
Closed -$22.4M

Similar funds

Hillhouse Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Hillhouse Investment Management held 52 positions worth $1.34B, down 64% from $3.74B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Hillhouse Investment Management withdrew a net $1.74B in Q4 2018, closing 28 positions and reducing 10 holdings. Its most notable exit was China Biologic Products Holdings, Inc., an estimated $220M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 42% of assets, up from 6.9% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Hillhouse Investment Management opened a new position in Moderna worth $14.9M.

  • Hillhouse Investment Management's largest Q4 2018 buy was Moderna: 978,434 shares worth $14.9M.
  • Hillhouse Investment Management added most to iQIYI in Q4 2018, an estimated $675M increase.
  • Hillhouse Investment Management's biggest Q4 2018 reduction was BeOne Medicines Ltd, cutting an estimated $589M.
  • Hillhouse Investment Management fully exited China Biologic Products Holdings, Inc. in Q4 2018, selling an estimated $220M.
  • Hillhouse Investment Management's ten largest holdings make up 93% of its $1.34B portfolio in Q4 2018.
  • Hillhouse Investment Management opened 2 new positions and closed 28 in Q4 2018.
  • Hillhouse Investment Management's portfolio value fell 64% quarter-over-quarter to $1.34B.

Based on Hillhouse Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.